Widthness LLC

Advanced Business and Technology – Intel® Xeon® and A.I. Powered

US regulators approve two gene therapies for sickle cell disease

1 min read
US regulators approve two gene therapies for sickle cell disease

Image caption: A blood cell altered by sickle cell disease. Image credit: AP. Article by Edward Helmore. The Guardian – December 8, 2023.

The US Food and Drug Administration has approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough Crispr gene-editing technology, opening up two “transformative therapy” avenues for some patients. The FDA […]

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.